GPAT (GP-Act III Acquisition) Current Accrued Expense: $1.79 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GPAT GP-Act III Acquisition Corp GPAT
16 GF Score
Price $10.93
! 1 Warning Sign
View Full Analysis

What is GP-Act III Acquisition Current Accrued Expense?

GP-Act III Acquisition GPAT 16 Current Accrued Expense is $1.79 Mil as of Jun. 2026. GuruFocus rates GPAT with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

GP-Act III Acquisition's Current Accrued Expense for the quarter that ended in Jun. 2026 was $1.79 Mil.

GP-Act III Acquisition's quarterly Current Accrued Expense increased from Dec. 2025 ($0.23 Mil) to Mar. 2026 ($0.70 Mil) and increased from Mar. 2026 ($0.70 Mil) to Jun. 2026 ($1.79 Mil).

GP-Act III Acquisition's annual Current Accrued Expense increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.23 Mil) and increased from Dec. 2024 ($0.23 Mil) to Dec. 2025 ($0.23 Mil).

GP-Act III Acquisition Current Accrued Expense Related Terms

GP-Act III Acquisition Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for GP-Act III Acquisition's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GP-Act III Acquisition Current Accrued Expense Chart

GP-Act III Acquisition Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
0.68 0.00 0.23 0.23

GP-Act III Acquisition Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.21 0.23 0.70 1.79
GPAT
16GF Score
GP-Act III Acquisition Corp GPAT
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GP-Act III Acquisition Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $1.79 Mil mean?
GP-Act III Acquisition (GPAT) has a Current Accrued Expense of $1.79 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on GP-Act III Acquisition and its competitors.
Is GP-Act III Acquisition's Current Accrued Expense too high?
GP-Act III Acquisition's current Current Accrued Expense is $1.79 Mil. Overall, GP-Act III Acquisition has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does GP-Act III Acquisition's Current Accrued Expense compare to GUAC and BBCQ?
GP-Act III Acquisition's Current Accrued Expense of $1.79 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Diversified Financial Services company?
A good Current Accrued Expense depends on the Diversified Financial Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on GP-Act III Acquisition and its competitors. GP-Act III Acquisition's current Current Accrued Expense is $1.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GP-Act III Acquisition stock overvalued right now?
GP-Act III Acquisition (GPAT) has a current Current Accrued Expense of $1.79 Mil. The current Current Accrued Expense is $1.79 Mil. GP-Act III Acquisition's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For GP-Act III Acquisition (GPAT), the current Current Accrued Expense is $1.79 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GP-Act III Acquisition Business Description

Address 300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
GP-Act III Acquisition Corp is a blank check company.
16GF Score

Get the complete analysis for GPAT

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.93
Price